Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 26, 2019 Filed Dec 27, 2019 21:02 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076466 · a4.xml · nonDerivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 4,000 F3 · kind: This transaction involved a gift of securities by the Reporting Person to his son. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 21:02 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076466 · a4.xml · nonDerivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,841 F3 · kind: This transaction involved a gift of securities by the Reporting Person to his son. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 21:02 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076466 · a4.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,941 F2 · kind: This transaction involved a gift of securities by the Reporting Person to another daughter, who does not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 21:02 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076466 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,041 F1 · kind: This transaction involved a gift of securities by the Reporting Person to his daughter, who does not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:27 UTC |
Khattar Jack A.Director · President, CEO
|
PurchaseCommon Stock | 7,200 | $26.39 | $189,982.08 |
DisclosureSEC source: 0001104659-19-047536 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,141 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.5100, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes an aggregate of 376 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 17:28 UTC |
PATRICK GREGORY SSr. VP,Chief Financial Officer
|
GiftCommon Stock | 2,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-043393 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr. VP,Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,682 F1 · balance_after: Includes an aggregate of 376 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:06 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-19-037264 · a4.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:06 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.13 | $91,300.00 |
DisclosureSEC source: 0001104659-19-037264 · a4.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 15:43 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-19-024504 · a4.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 15:43 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.13 | $91,300.00 |
DisclosureSEC source: 0001104659-19-024504 · a4.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 20, 2019 21:19 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 4,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-016356 · a4.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the KBT Trust Disclosed balance after: 1,081,450 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 4,500 shares were transferred from the KBT Trust to the Reporting Person on March 20, 2019 without consideration and are now owned directly. Read SEC document |
| March 20, 2019 Filed Mar 20, 2019 21:19 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 4,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-016356 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,565 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 4,500 shares were transferred from the KBT Trust to the Reporting Person on March 20, 2019 without consideration and are now owned directly. F1 · balance_after: The Reporting Person is filing this Form 4 to reflect the fact that 4,500 shares were transferred from the KBT Trust to the Reporting Person on March 20, 2019 without consideration and are now owned directly. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 16:29 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-19-011559 · a4.xml · derivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 20,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2016. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 16:29 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
SaleCommon Stock | 20,000 | $41.53 | $830,650.00 |
DisclosureSEC source: 0001104659-19-011559 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,896 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.0000 to $42.1900, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 16:29 UTC |
PATRICK GREGORY SSr VP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $9.13 | $182,600.00 |
DisclosureSEC source: 0001104659-19-011559 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted November 28, 2018. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:25 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010795 · a4.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:26 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010798 · a4.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:24 UTC |
SIEBERT JOHN MDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010794 · a4.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:27 UTC |
PATRICK GREGORY SSr.VP,Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010799 · a4.xml · derivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · Sr.VP,Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-02-22 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2020. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:25 UTC |
GEMAYEL GEORGESDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010797 · a4.xml · derivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:28 UTC |
Khattar Jack A.Director · President, CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010802 · a4.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-02-22 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2020. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:28 UTC |
Schwabe Stefan K.F.Executive Vice President R&D
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010801 · a4.xml · derivative · entry 2 Schwabe Stefan K.F. · CIK 0001557657 · Executive Vice President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-02-22 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2020. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:27 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010800 · a4.xml · derivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-02-22 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2020. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:25 UTC |
Barlow CarroleeDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-010796 · a4.xml · derivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| February 22, 2019 Filed Mar 4, 2019 17:52 UTC Amendment |
SIEBERT JOHN MDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001104659-19-012549 · a4a.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,427 Underlying: Common Stock · 12,427 shares Expires 2029-02-22 Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:04 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-002327 · a4.xml · nonDerivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 2,900 F4 · kind: This transaction involved a gift of securities by the Reporting Person to his son. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:04 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-002327 · a4.xml · nonDerivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,065 F4 · kind: This transaction involved a gift of securities by the Reporting Person to his son. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:04 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-002327 · a4.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,465 F3 · kind: This transaction involved a gift of securities by the Reporting Person to another daughter, who does not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 23:04 UTC |
Khattar Jack A.Director · President, CEO
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-002327 · a4.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,865 F1 · kind: This transaction involved a gift of securities by the Reporting Person to his daughter, who does not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his daughter, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his daughter's shares for purposes of Section 16 or for any other purpose. F2 · balance_after: Includes an aggregate of 521 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. Read SEC document |
| December 03, 2018 Filed Feb 26, 2019 18:59 UTC |
PATRICK GREGORY SSr.VP, Chief Financial Officer
|
GiftCommon Stock | 8,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-010791 · a5.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · Sr.VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,896 F1 · balance_after: Includes an aggregate of 521 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. Read SEC document |
| August 20, 2018 Filed Mar 4, 2019 17:41 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,457 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-19-012547 · a4.xml · derivative · entry 4 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,457 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Mar 4, 2019 17:41 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 8,722 | $0.00 Strike: $7.90 | $0.00 |
DisclosureSEC source: 0001104659-19-012547 · a4.xml · derivative · entry 3 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,722 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Mar 4, 2019 17:41 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionCommon Stock | 7,457 | $9.24 | $68,902.68 |
DisclosureSEC source: 0001104659-19-012547 · a4.xml · nonDerivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Mar 4, 2019 17:41 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionCommon Stock | 8,722 | $7.90 | $68,903.80 |
DisclosureSEC source: 0001104659-19-012547 · a4.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 15:27 UTC |
PATRICK GREGORY SVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-18-043825 · a4.xml · derivative · entry 5 PATRICK GREGORY S · CIK 0001219844 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 15,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018. F4 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2016. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 15:27 UTC |
PATRICK GREGORY SVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-18-043825 · a4.xml · derivative · entry 4 PATRICK GREGORY S · CIK 0001219844 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on January 21, 2015. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 15:27 UTC |
PATRICK GREGORY SVP, Chief Financial Officer
|
SaleCommon Stock | 35,000 | $56.63 | $1,981,913.50 |
DisclosureSEC source: 0001104659-18-043825 · a4.xml · nonDerivative · entry 3 PATRICK GREGORY S · CIK 0001219844 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,975 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.0000 to $58.5500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 15:27 UTC |
PATRICK GREGORY SVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $9.13 | $136,950.00 |
DisclosureSEC source: 0001104659-18-043825 · a4.xml · nonDerivative · entry 2 PATRICK GREGORY S · CIK 0001219844 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 15:27 UTC |
PATRICK GREGORY SVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $9.24 | $184,800.00 |
DisclosureSEC source: 0001104659-18-043825 · a4.xml · nonDerivative · entry 1 PATRICK GREGORY S · CIK 0001219844 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted June 1, 2018. Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 22:03 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
SaleCommon Stock | 4,393 | $59.90 | $263,153.00 |
DisclosureSEC source: 0001104659-18-043279 · a4.xml · nonDerivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.9000 to $59.9500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| June 28, 2018 Filed Jun 29, 2018 22:03 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 295 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-18-043279 · a4.xml · derivative · entry 4 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 295 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. F4 · derivative.exercise_date: The option became exercisable in four equal installments beginning on March 3, 2016, which was the first anniversary of the date on which the option was granted. Read SEC document |
| June 28, 2018 Filed Jun 29, 2018 22:03 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
SaleCommon Stock | 3,402 | $59.94 | $203,899.21 |
DisclosureSEC source: 0001104659-18-043279 · a4.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,393 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.9000 to $60.0250, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 28, 2018 Filed Jun 29, 2018 22:03 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionCommon Stock | 295 | $9.13 | $2,693.35 |
DisclosureSEC source: 0001104659-18-043279 · a4.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. Read SEC document |
| June 27, 2018 Filed Jul 2, 2018 21:52 UTC |
Barlow CarroleeDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 10,213 | $0.00 Strike: $58.15 | $0.00 |
DisclosureSEC source: 0001104659-18-043597 · a4.xml · derivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,213 Underlying: Common Stock · 10,213 shares Expires 2028-06-27 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on June 27, 2019. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 21:30 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,205 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0001104659-18-041853 · a4.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,295 Underlying: Common Stock · 7,205 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. F3 · derivative.exercise_date: The option became exercisable in four equal installments beginning on March 3, 2016, which was the first anniversary of the date on which the option was granted. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 21:30 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
SaleCommon Stock | 7,205 | $60.00 | $432,323.06 |
DisclosureSEC source: 0001104659-18-041853 · a4.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.9000 to $60.3500, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 21:30 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionCommon Stock | 7,205 | $9.13 | $65,781.65 |
DisclosureSEC source: 0001104659-18-041853 · a4.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 14, 2017. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 21:51 UTC |
Schwabe Stefan K.F.Executive VP R&D, CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-18-041086 · a4.xml · derivative · entry 5 Schwabe Stefan K.F. · CIK 0001557657 · Executive VP R&D, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted May 17, 2018. F4 · derivative.exercise_date: The option became exercisable in four equal installments beginning on January 21, 2015, which was the first anniversary of the date on which the option was granted. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 21:51 UTC |
Schwabe Stefan K.F.Executive VP R&D, CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.90 | $0.00 |
DisclosureSEC source: 0001104659-18-041086 · a4.xml · derivative · entry 4 Schwabe Stefan K.F. · CIK 0001557657 · Executive VP R&D, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted May 17, 2018. F3 · derivative.exercise_date: The option became exercisable in four equal installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 21:51 UTC |
Schwabe Stefan K.F.Executive VP R&D, CMO
|
SaleCommon Stock | 60,000 | $54.39 | $3,263,352.00 |
DisclosureSEC source: 0001104659-18-041086 · a4.xml · nonDerivative · entry 3 Schwabe Stefan K.F. · CIK 0001557657 · Executive VP R&D, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,967 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted May 17, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.000 to $54.900, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.